D. Powers

发表

Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults.

K. Lottenbach, E. Anderson, D. Powers, 1996, The Journal of infectious diseases.

Effect of age on the human high affinity interleukin 2 receptor of phytohaemagglutinin stimulated peripheral blood lymphocytes.

D. Powers, R. Chopra, J. Nagel, 1989, Clinical and experimental immunology.

Influenza A Virus‐Specific Cytotoxic T Lymphocyte Activity Declines with Advancing Age

D. Powers, 1993, Journal of The American Geriatrics Society.

Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine

D. Powers, 1994, Journal of medical virology.

Interleukin 2, interleukin 2 receptor, and interferon-gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans.

N. Holbrook, M. McCoy, D. Powers, 1989, Clinical immunology and immunopathology.

In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant.

P. Pietrobon, D. Powers, P. J. Hanscome, 1995, Vaccine.

The confounded effects of age and exposure history in response to influenza vaccination.

Judith M. Fonville, Derek J. Smith, J. M. Fonville, 2016, Vaccine.

Influenza virus vaccination of patients with chronic lung disease.

F. Newman, G. Gorse, D. Powers, 1997, Chest.

Summary of a clinical trial with liposome-adjuvanted influenza A virus vaccine in elderly adults

D. Powers, 1997, Mechanisms of Ageing and Development.

Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus.

M. Manning, J. McElhaney, D. Powers, 1997, The Journal of infectious diseases.

Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F

A. Lucas, D. Granoff, R. Mandrell, 1997, Infection and immunity.

Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine.

R. Belshe, D. Powers, 1993, The Journal of infectious diseases.

J. Morley, J. Flood, D. Powers, 1992, Cellular immunology.

Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults

E. D. Kilbourne, D. Powers, B. Johansson, 1996, Clinical and diagnostic laboratory immunology.

Safety and Immunogenicity of Haemophilus Influenzae Type B Polysaccharide or Conjugate Vaccines in an Elderly Adult Population

S. Homan, D. Granoff, K. Lottenbach, 2004, Journal of the American Geriatrics Society.

Hepatitis B Virus Vaccination for Older Adults

M. Clements, R. Bennett, R. Remsburg, 1996, Journal of the American Geriatrics Society.

Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and "original antigenic sin".

R. Belshe, D. Powers, 1994, The Journal of infectious diseases.

Age-Associated Differences in Immunoglobulin G1 (IgG1) and IgG2 Subclass Antibodies to Pneumococcal Polysaccharides following Vaccination

S. Homan, K. Lottenbach, E. Anderson, 1999, Infection and Immunity.

Expression of interleukin 2 and the interleukin 2 receptor in aging rats.

N. Holbrook, M. McCoy, D. Powers, 1989, Cellular immunology.

PSYCHONEUROIMMUNOLOGY AND AGING

J. Morley, D. Powers, 1993, Journal of the American Geriatrics Society.

Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

R. Betts, R. Belshe, J. Treanor, 1996, The Journal of infectious diseases.

Immunological Principles and Emerging Strategies of Vaccination for the Elderly

D. Powers, 1992, Journal of the American Geriatrics Society.

Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines

B. Murphy, M. Clements, D. Powers, 1989, Journal of clinical microbiology.

Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly.

F. Newman, G. Gorse, D. Powers, 1996, The Journal of infectious diseases.

Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly.

M. Manning, P. Pietrobon, D. Powers, 1995, The Journal of infectious diseases.

Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine.

F. Newman, G. Gorse, D. Powers, 1995, The Journal of infectious diseases.

Phorbol myristate acetate and calcium ionophore A23187-stimulated human T cells do not express high-affinity IL-2 receptors.

D. Powers, R. Chopra, J. Nagel, 1989, Immunology.

Soluble interleukin 2 receptors released from mitogen stimulated human peripheral blood lymphocytes bind interleukin 2 and inhibit IL2 dependent cell proliferation.

N. Kendig, D. Powers, R. Chopra, 1989, Immunological investigations.

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults.

R. Belshe, J. Treanor, Gale Smith, 1995, The Journal of infectious diseases.

Reduced Infectivity of Cold‐Adapted Influenza A H1N1 Viruses in the Elderly: Correlation with Serum and Local Antibodies

B. Murphy, M. Clements, L. Fries, 1992, Journal of the American Geriatrics Society.

In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory

B. Murphy, M. Clements, L. Fries, 1991, Journal of clinical microbiology.

Increased immunogenicity of inactivated influenza virus vaccine containing purified surface antigen compared with whole virus in elderly women

D. Powers, 1994, Clinical and diagnostic laboratory immunology.